Am. J. Respir. Crit. Care Med., Volume 160, Number 3, September 1999, 961-967

Cytokines IL-1, IL-6, and TNF- Enhance In Vitro Growth of Bacteria

G. UMBERTO MEDURI, SIVA KANANGAT, JENNIFER STEFAN, ELIZABETH TOLLEY, and DENNIS SCHABERG

Memphis Lung Research Program, Department of Medicine, Divisions of Pulmonary and Critical Care Medicine, and Infectious Disease and Department of Preventive Medicine, University of Tennessee, and Veterans Affairs Medical Center, Memphis, Tennessee

We have previously reported that in acute respiratory distress syndrome (ARDS), nonsurvivors have persistent elevation in pulmonary and circulating proinflammatory cytokine levels over time and a high rate of nosocomial infections antemortem. In these patients, none of the proven or suspected nosocomial infections caused a transient or sustained increase in plasma proinflammatory cytokine levels above preinfection values. We hypothesized that cytokines secreted by the host during ARDS may favor the growth of bacteria. We conducted an in vitro study of the growth of three bacteria clinically relevant in nosocomial infections, evaluating their in vitro response to various concentrations of tumor necrosis factor (TNF)-, interleukin (IL)-1, and IL-6. We found that all three bacterial species showed concentration-dependent growth enhancement when incubated with one or more tested cytokines and that blockade by specific neutralizing cytokine MoAb significantly inhibited cytokine-induced growth. When compared with control, the 6-h growth response (cfu/ml) was maximal with IL-1 at 1,000 pg for Staphylococcus aureus (36 ± 16 versus 377 ± 16; p = 0.0001) and Acinetobacter spp. (317 ± 1,147 versus 1,124 ± 147; p = 0.002) and with IL-6 at 1,000 pg for Pseudomonas aeruginosa (99 ± 50 versus 509 ± 50; p = 0.009). The effects of cytokines were seen only with fresh isolates and were lost with passage in vitro on bacteriologic medium without added cytokines. In this study we provide additional evidence for a newly described pathogenetic mechanism for bacterial proliferation in the presence of exaggerated and protracted inflammation.

This article has been cited by other articles:

				J. P. Mizgerd Acute Lower Respiratory Tract Infection N. Engl. J. Med., February 14, 2008; 358(7): 716 - 727. [Full Text] [PDF]

				G. A. Hecht Inflammatory Bowel Disease -- Live Transmission N. Engl. J. Med., January 31, 2008; 358(5): 528 - 530. [Full Text] [PDF]

				G. Cappabianca, D. Paparella, G. Visicchio, G. Capone, G. Lionetti, F. Numis, P. Ferrara, C. D'Agostino, and L. de Luca Tupputi Schinosa Preoperative C-Reactive Protein Predicts Mid-Term Outcome After Cardiac Surgery Ann. Thorac. Surg., December 1, 2006; 82(6): 2170 - 2178. [Abstract] [Full Text] [PDF]

				S. Yende, E. I. Tuomanen, R. Wunderink, A. Kanaya, A. B. Newman, T. Harris, N. de Rekeneire, S. B. Kritchevsky, and for the Health ABC Study Preinfection Systemic Inflammatory Markers and Risk of Hospitalization Due to Pneumonia Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1440 - 1446. [Abstract] [Full Text] [PDF]

				I. Ciubotaru, L. A. Potempa, and R. C. Wander Production of Modified C-Reactive Protein in U937-Derived Macrophages Experimental Biology and Medicine, November 1, 2005; 230(10): 762 - 770. [Abstract] [Full Text] [PDF]

				J. P. Mizgerd, M. M. Lupa, J. Hjoberg, J. C. Vallone, H. B. Warren, J. P. Butler, and E. S. Silverman Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1 Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1302 - L1310. [Abstract] [Full Text] [PDF]

				J. P. Mizgerd Competing Benefits of Tumor Necrosis Factor-{alpha} for Bacteria and for Host Defense Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1410 - 1411. [Full Text] [PDF]

				J.-H. Lee, L. Del Sorbo, A. A. Khine, J. de Azavedo, D. E. Low, D. Bell, S. Uhlig, A. S. Slutsky, and H. Zhang Modulation of Bacterial Growth by Tumor Necrosis Factor-{alpha} In Vitro and In Vivo Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1462 - 1470. [Abstract] [Full Text] [PDF]

				G. U. Meduri, S. Kanangat, M. Bronze, D. R. Patterson, C. U. Meduri, C. Pak, E. A. Tolley, and D. R. Schaberg Effects of Methylprednisolone on Intracellular Bacterial Growth Clin. Vaccine Immunol., November 1, 2001; 8(6): 1156 - 1163. [Abstract] [Full Text] [PDF]

				H.-D. HELD, S. BOETTCHER, L. HAMANN, and S. UHLIG Ventilation-Induced Chemokine and Cytokine Release Is Associated with Activation of Nuclear Factor-{kappa}B and Is Blocked by Steroids Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 711 - 716. [Abstract] [Full Text] [PDF]

				S. Teramoto, T. Ishii, M. Luisetti, and P. F. Pignatti No Association of Tumor Necrosis Factor-{{alpha}} Gene Polymorphism and COPD in Caucasian Smokers and Japanese Smokers Chest, January 1, 2001; 119(1): 315 - 316. [Full Text] [PDF]